A Phase II trial of vinorelbine tartrate
β
Robert P. Whitehead; James Moon; S. Spence McCachren; Evan M. Hersh; Wolfram E.
π
Article
π
2004
π
John Wiley and Sons
π
English
β 84 KB
π 2 views
## Abstract ## BACKGROUND Singleβagent chemotherapy with dacarbazine continues to be the standard of care for the treatment of metastatic melanoma. However, there is a large population of patients who have failed firstβline therapy and might benefit from additional treatment. In the current study,